Form 4: Oaktree Acquisition Corp. III Life Sciences: Major Shareholder Activity Following Underwriters' Over-Allotment Option

Oaktree Acquisition Holdings III LS, LLC reports changes in beneficial ownership of Oaktree Acquisition Corp. III Life Sciences securities following the partial exercise of the underwriters' over-allotment option.

Summary

• Oaktree Acquisition Holdings III LS, LLC filed a Form 4 detailing changes in beneficial ownership of Oaktree Acquisition Corp. III Life Sciences [OACC] securities.
• The filing is related to the partial exercise of the over-allotment option by the underwriters of the issuer's initial public offering on October 30, 2024.
• Oaktree Acquisition Holdings III, LLC purchased 33,981 additional private placement units at $10.00 per unit.
• These units consist of Class A ordinary shares and warrants.
• Concurrently, Oaktree Acquisition Holdings III, LLC forfeited 231,492 Class B ordinary shares at no cost due to the partial exercise of the over-allotment option.
• The filing also reflects the ownership of private placement warrants exercisable for Class A ordinary shares.
• The reporting persons include Oaktree Acquisition Holdings III LS, LLC and related entities, as well as Brookfield Corporation, Brookfield Asset Management, Ltd., and BAM Partners Trust.
• The filing clarifies the relationships between these entities and their indirect beneficial ownership of the securities.

Sentiment

Score: 6

Explanation: The document is a routine filing related to post-IPO activities. While it involves the purchase and forfeiture of shares, it doesn't inherently indicate positive or negative sentiment. The sentiment is neutral to slightly positive due to the additional investment.

Negatives

• Oaktree Acquisition Holdings III, LLC forfeited 231,492 Class B ordinary shares, although this was at no cost.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders, providing transparency to the market.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares and warrants.

Key Dates